Topical Naringenin for Hair Regrowth - Quick Reference Sheet
evipedia.ai ← Back

Topical Naringenin for Hair Regrowth

Created on 07/31/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A citrus-derived compound applied to the scalp in the hope of slowing hair loss and spurring regrowth. Evidence is early and thin: only cell and animal work exists, with no human testing, so any benefit is unproven. Likely downsides are modest, mainly skin irritation. Best approached as a plausible but experimental option. (Full Review)

Protocol

Concentration
0.5%
Compounded in ethanol, propylene glycol, or a nanoemulsion vehicle to aid skin penetration
Frequency
Twice daily
Applied to the dry scalp; split dosing preferred over once daily given brief local action
Approach
Standalone or add-on
Best animal result paired it with 5% minoxidil; microneedling boosts delivery
Time to effect
Visible change
3–6 months
At least one full hair cycle of consistent use before any judgement is possible

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Active hormone-sensitive cancers
  • Known citrus-flavonoid allergy
  • Broken, infected, or inflamed scalp skin
    •
Key Interactions
  • Topical retinoids (tretinoin, adapalene)
  • CYP3A4-dependent drugs (statins, calcium-channel blockers, immunosuppressants)
  • Alcohol-based scalp products and exfoliants (salicylic acid)
  • Oral naringenin supplements and grapefruit extract
  • Microneedling
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Application-site skin irritation
    •
  • Speculative: Contact allergy or sensitization; hormonal effects from systemic exposure; interference with drug metabolism; unknown long-term topical safety
    •

Monitoring

Marker Target Why
Ferritin 40–70 ng/mL Low iron stores independently impair hair growth
Vitamin D (25-hydroxyvitamin D) 40–60 ng/mL Deficiency is associated with hair loss and poor follicle cycling
Thyroid-stimulating hormone (TSH) 0.5–2.5 mIU/L Thyroid dysfunction is a common, reversible cause of shedding

Cadence: Standardized photographs every 8–12 weeks; trichoscopy and blood tests every 3–6 months

Qualitative Assessment

  • Reduced daily shedding (fewer hairs on the pillow, in the shower, or on the brush)
  • Appearance of fine new (vellus) regrowth along the hairline or part
  • Improved perceived hair thickness, coverage, and quality
  • Scalp comfort — absence of irritation, itching, or redness from the product
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.